The overall trend of insiders is illustrated in the chart below:
Time Warner Inc. (NYSE:TWX): Director William P. Barr Bought 4,111 Shares
Director of Time Warner Inc., William P. Barr, bought 4,111 shares during the past week at an average price of $37.69. Time Warner Inc. is the world's media and entertainment company, whose businesses include filmed entertainment, interactive services, television networks, cable systems, publishing and music. Time Warner Inc. has a market cap of $37.72 billion; its shares were traded at around $37.69 with a P/E ratio of 12.95 and P/S ratio of 1.3. The dividend yield of Time Warner Inc. stocks is 2.49%.
On February 8, Time Warner Inc. reported results for the fourth quarter of 2011. Revenues increased 5% from the year-ago quarter to $8.2 billion, reflecting higher revenues at the Filmed
Entertainment and Networks segments. Adjusted operating income rose 20% to $1.7 billion. Operating income increased 17% to $1.7 billion in the quarter, while operating
income margins were 20% compared to 18% in the 2010 quarter.
Last week, Director William P. Barr bought 2,624 shares of TWX stock. Executive Vice President Olaf Olafsson, CF and AO John K. Martin, Executive Vice President and General Counsel Paul T. Cappuccio, Executive Vice President Carol A. Melton, and Chairman of the Board and CEO Jeffrey L. Bewkes sold shares this month.
Gilead Sciences (NASDAQ:GILD): Director Olsen Per Wold Bought 10,000 Shares
Director of Gilead Sciences, Olsen Per Wold, bought 10,000 shares on 2/22/2012 at an average price of $45.26. Gilead Sciences Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. Gilead Sciences has a market cap of $34 billion; its shares were traded at around $45.26 with a P/E ratio of 12.37 and P/S ratio of 4.05. Gilead Sciences had an annual average earnings growth of 47.1% over the past 10 years.
On February 2, Gilead Sciences Inc. announced today its results of operations for the fourth quarter and full year 2011. Total revenues for the fourth quarter of 2011 increased 10 percent to $2.20 billion, from $2.00 billion for the fourth quarter of 2010. Net income for the fourth quarter of 2011 was $665.1 million, or $0.87 per diluted share, compared to $629.4 million, or $0.76 per diluted share for the fourth quarter of 2010.
Last week, Director Olsen Per Wold bought 10,000 shares of GILD stock. Director Nicholas G. Moore, Director Etienne Davignon, Senior Vice Presidnet Human Resources Kristen Metza, Senior Vice President Human Resources Kristen Metza, Senior Vice President and CFO Robin L Washington and Chairman and CEO John C. Martin sold shares this month.
Dell Inc. (NASDAQ:DELL): President John A. Swainson Bought 100,000 Shares
President of Dell Inc. John A. Swainson bought 100,000 shares on 2/23/2012 at an average price of $17.43. Dell Inc. is a premier provider of products and services required for customers worldwide to build their information-technology and Internet infrastructures. Dell Inc. has a market cap of $31.31 billion; its shares were traded at around $17.43 with a P/E ratio of 8.14 and P/S ratio of 0.5. Dell Inc. had an annual average earnings growth of 4.2% over the past 10 years.
On February 21, Dell Inc. reported results for the fourth fiscal quarter of 2012. Revenue in the quarter was $16 billion, a 2 percent increase over the previous year. GAAP earnings per share in the quarter was 43 cents, down 10 percent from the previous year; non-GAAP EPS was 51 cents, down 4 percent. For the fiscal year, GAAP EPS was $1.88, up 39 percent year over year and Non-GAAP EPS was $2.13, up 34 percent, both records. GAAP operating income was $1.1 billion, or 7.1 percent of revenue. For the fiscal year, GAAP operating income was $4.4 billion and non-GAAP operating income was $5.1 billion, both records.
Last week, President John A. Swainson bought 100,000 shares of DELL stock. Director Thomas W. Luce III sold 14,734 shares last month. CAO Thomas W. Sweet and Senior Vice President Brian T. Gladden sold shares in December.
Northrop Grumman Corp. (NYSE:NOC): Director Thomas M. Schoewe Bought 1,660 Shares
Director of Northrop Grumman Corp. Thomas M. Schoewe bought 1,660 shares on 2/22/2012 at an average price of $59.92. Northrop Grumman Corporation is a high technology company providing innovative solutions in systems integration, defense electronics and information technology. Northrop Grumman Corp. has a market cap of $15.66 billion; its shares were traded at around $59.92 with a P/E ratio of 9.2 and P/S ratio of 0.59. The dividend yield of Northrop Grumman Corp. stocks is 3.34%. Northrop Grumman Corp. had an annual average earnings growth of 13% over the past 10 years. GuruFocus rated Northrop Grumman Corp. the business predictability rank of 3.5-star.
On February 1, Northrop Grumman Corporation reported that fourth quarter 2011 earnings from continuing operations increased 80 percent to $550 million, or $2.09 per diluted share, from $306 million, or $1.03 per diluted share, in the fourth quarter of 2010. Fourth quarter 2010 results included a pre-tax charge of $229 million, or $0.50 per diluted share, principally related to premiums paid to redeem $682 million in debt in 2010. Fourth quarter 2011 diluted earnings per share are based on 262.7 million weighted average shares outstanding compared with 296.9 million shares in the fourth quarter of 2010.
Last week, Director Thomas M. Schoewe bought 1,660 shares of NOC stock. Corp. Vice President and President Information Systems Linda A. Mills bought 1,375 shares in November. Corporate Vice President and President Systems Gary W. Ervin, Director Aulana L. Peters and Corporate Vice President and President Electronic Systems James F. Pitts sold shares this month.
Boston Scientific Corp. (NYSE:BSX): Director Ernest Mario Bought 30,000 Shares
Director of Boston Scientific Corp. (NYSE:BSX) Ernest Mario bought 30,000 shares during the past week at an average price of $6.25. Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. Boston Scientific Corp. has a market cap of $9.26 billion; its shares were traded at around $6.25 with a P/E ratio of 13.02 and P/S ratio of 1.21.
On February 2, Boston Scientific Corp. reported results for the fourth quarter of 2011. Sales for the fourth quarter of 2011 were $1.848 billion, as compared to sales of $2.002 billion for the fourth quarter of 2010, a decrease of 8 percent. On a GAAP basis, net income for the fourth quarter of 2011 was $107 million, or $0.07 per share.
Last week, Director Ernest Mario bought 10,000 shares of BSX stock. Director NJ Nicholas Jr., Director Katharine T. Bartlett, and Director Ernest Mario bought shares in November.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.